https://transhumanist.ru/index.php?action=history&feed=atom&title=CH25H 2026-06-23T04:05:45Z История изменений этой страницы в вики MediaWiki 1.43.6 https://transhumanist.ru/index.php?title=CH25H&diff=6197&oldid=prev 2021-05-12T15:16:29Z

<p>Новая страница: «Cholesterol 25-hydroxylase (EC 1.14.99.38) (Cholesterol 25-monooxygenase) (h25OH) ==Publications== {{medline-entry |title=Atherosclerosis and Alzheimer--disease...»</p> <p><b>Новая страница</b></p><div>Cholesterol 25-hydroxylase (EC 1.14.99.38) (Cholesterol 25-monooxygenase) (h25OH)<br /> <br /> ==Publications==<br /> <br /> {{medline-entry<br /> |title=Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature.<br /> |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24656052<br /> |abstract=Aging is accompanied by increasing vulnerability to pathologies such as atherosclerosis (ATH) and Alzheimer disease (AD). Are these different pathologies, or different presentations with a similar underlying pathoetiology? Both ATH and AD involve inflammation, macrophage infiltration, and occlusion of the vasculature. Allelic variants in common genes including [[APOE]] predispose to both diseases. In both there is strong evidence of disease association with viral and bacterial pathogens including herpes simplex and Chlamydophila. Furthermore, ablation of components of the immune system (or of bone marrow-derived macrophages alone) in animal models restricts disease development in both cases, arguing that both are accentuated by inflammatory/immune pathways. We discuss that amyloid β, a distinguishing feature of AD, also plays a key role in ATH. Several drugs, at least in mouse models, are effective in preventing the development of both ATH and AD. Given similar age-dependence, genetic underpinnings, involvement of the vasculature, association with infection, Aβ involvement, the central role of macrophages, and drug overlap, we conclude that the two conditions reflect different manifestations of a common pathoetiology. Infection and inflammation selectively induce the expression of cholesterol 25-hydroxylase ([[CH25H]]). Acutely, the production of &#039;immunosterol&#039; 25-hydroxycholesterol (25OHC) defends against enveloped viruses. We present evidence that chronic macrophage [[CH25H]] upregulation leads to catalyzed esterification of sterols via 25OHC-driven allosteric activation of ACAT (acyl-CoA cholesterol acyltransferase/SOAT), intracellular accumulation of cholesteryl esters and lipid droplets, vascular occlusion, and overt disease. We postulate that AD and ATH are both caused by chronic immunologic challenge that induces [[CH25H]] expression and protection against particular infectious agents, but at the expense of longer-term pathology.<br /> |mesh-terms=* Aging<br /> * Alzheimer Disease<br /> * Amyloid beta-Peptides<br /> * Animals<br /> * Atherosclerosis<br /> * Brain<br /> * Humans<br /> * Hydroxycholesterols<br /> * Inflammation<br /> * Inflammation Mediators<br /> <br /> |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994432<br /> }}</div>

OdysseusBot